BMS stockholders flock to spinoff offer

Bristol-Myers Squibb said its stock-swap offer as part of its spinoff of Mead Johnson Nutrition attracted nearly twice as many shares as it can exchange, so holders who tendered at least 100 shares will get 53.8 percent swapped for Mead Johnson stock. Report